This inventor holds 1 USPTO granted patent. Top assignees: Southern Research Institute, University of Rochester. Active years: 2014.
Company Filing History:
1 out of 205 
1 out of 994 
Years Active: 2014
Title: Krister Wennerberg: Innovator in Lifespan Alteration
Introduction
Krister Wennerberg is a notable inventor based in Helsinki, Norway. He has made significant contributions to the field of biochemistry, particularly in the area of lifespan alteration in eukaryotic organisms. His innovative work has implications for both aging research and inflammation treatment.
Latest Patents
Wennerberg holds a patent for "Compounds and methods for altering lifespan of eukaryotic organisms." This patent includes compounds that generally have a triketone structure. Examples of these compounds are derivatives of 1,3-cyclohexanedione, such as 1,3-cyclohexanedione, 2-propanoyl-5-cyclohexyl-; 1,3-cyclohexanedione, 2-propanoyl-5-[4-fluorophenyl]-; and 1,3-cyclohexanedione, 2-acetyl-5-[thien-2-yl]-. These compounds can be utilized to alter the lifespan of eukaryotic organisms and to treat inflammation.
Career Highlights
Throughout his career, Krister Wennerberg has worked with esteemed institutions such as the University of Rochester and Southern Research Institute. His research has focused on the biochemical pathways that influence aging and inflammation, leading to innovative solutions in these areas.
Collaborations
Wennerberg has collaborated with notable professionals in his field, including David S. Goldfarb and Joseph A. Maddry. These collaborations have enriched his research and contributed to the advancement of knowledge in lifespan alteration.
Conclusion
Krister Wennerberg is a pioneering inventor whose work on compounds for altering lifespan has the potential to impact both aging and inflammation treatment significantly. His contributions to the field are noteworthy and continue to inspire further research and innovation.